MARINUS PHARMACEUTICALS INC's ticker is and the CUSIP is 56854Q200. A total of 85 filers reported holding MARINUS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $7,047,406 | -66.4% | 1,770,705 | -43.9% | 1.19% | -63.4% |
| Q3 2022 | $20,993,000 | +37.4% | 3,156,803 | 0.0% | 3.24% | +7.6% |
| Q2 2022 | $15,279,000 | -48.2% | 3,156,803 | 0.0% | 3.01% | -37.1% |
| Q1 2022 | $29,516,000 | -13.7% | 3,156,803 | +9.6% | 4.78% | +2.2% |
| Q4 2021 | $34,216,000 | +13.8% | 2,880,096 | +9.0% | 4.68% | +21.1% |
| Q3 2021 | $30,064,000 | -36.6% | 2,641,809 | 0.0% | 3.86% | -32.8% |
| Q2 2021 | $47,394,000 | +15.9% | 2,641,809 | 0.0% | 5.75% | +29.6% |
| Q1 2021 | $40,895,000 | +29.5% | 2,641,809 | +2.0% | 4.44% | -4.5% |
| Q4 2020 | $31,585,000 | – | 2,588,941 | – | 4.64% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lion Point Capital, LP | 2,145,337 | $17,269,963 | 7.70% |
| Bleichroeder LP | 1,872,463 | $15,073,327 | 3.72% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5,204,942 | $41,899,783 | 2.26% |
| Opaleye Management Inc. | 584,000 | $4,701,200 | 1.53% |
| Bain Capital Life Sciences Investors, LLC | 1,431,058 | $11,520,017 | 1.29% |
| Cormorant Asset Management, LP | 2,625,000 | $21,131,250 | 1.23% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 290,000 | $2,337,400 | 0.79% |
| Ikarian Capital, LLC | 746,069 | $6,005,856 | 0.72% |
| Eventide Asset Management | 4,529,997 | $36,466,476 | 0.66% |
| Altium Capital Management LP | 125,033 | $1,006,516 | 0.52% |